3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
6
Brain Neoplasms
3
Pain
2
Neuralgia
2
Glioma
2
Depression
2
Visceral Pain
1
Rectal Neoplasms
1
Pituitary Neoplasms
1
Pancreatic Neoplasms
1
Neurologic Manifestations
1
Language Disorders
1
Headache
1
Glioblastoma
1
Fatigue
1
Cognitive Dysfunction
1
Carcinoma, Renal Cell
1
Cancer Survivor
1
Anxiety Disorders
1
Agnosia
1
Acromegaly
1
Interventions
Exercise
6
Transcranial Direct Current Stimulation
4
Walking
3
Memantine
3
Tablets
2
Standard of Care
2
Methods
2
Donepezil
2
Cognitive Behavioral Therapy
2
mazdutide
1
lithium sulfate
1
lime
1
fasudil
1
enzalutamide
1
blueberry extract
1
beta Carotene
1
acetaminophen, aspirin, caffeine drug combination
1
XENP 1595
1
Vitamin E
1
Vitamin D
1
Ultraviolet Therapy
1
Transcranial Magnetic Stimulation
1
Time
1
Therapeutics
1
Tai Ji
1
Sugars
1
Sodium Chloride
1
Sirolimus
1
Silymarin
1
Riluzole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Cognitive Dysfunction
×
Transcranial Magnetic Stimulation
×
Clear all
NCT06589544
2024-09-19
INCEPT
University Hospital of Ferrara
Phase NA
Recruiting
100 enrolled